{
  "type": "hyp",
  "text": "Activation also induced c-rel and p105/p50 NF-kappaB synthesis but not p65 NF-kappaB whose expression was constitutive.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "Activation",
        "c-rel and p105/p50 NF-kappaB synthesis",
        "not p65 NF-kappaB",
        "whose expression"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What induced c-rel and p105/p50 NF-k",
          "What did activation of p65 NF-kappaB induce?",
          "What NF-kappaB expression was constitutive?",
          "What was constitutive?"
        ]
      }
    }
  },
  "asked": {
    "What is the activator of phase-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.002242743968963623,
        "ground_truth": {
          "protein-1": {
            "bertscore": 0.6568500995635986,
            "f1": 0
          }
        }
      }
    },
    "What antibiotic significantly reduced phase-2 response?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0035721659660339355,
        "ground_truth": {
          "actinomycin D": {
            "bertscore": 0.5445255637168884,
            "f1": 0
          }
        }
      }
    },
    "What was used to inhibit phase-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.001504063606262207,
        "ground_truth": {
          "cycloheximide": {
            "bertscore": 0.5792067050933838,
            "f1": 0
          }
        }
      }
    },
    "What did the pretreatment with actinomycin D and cycloheximide": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.06647258996963501,
        "ground_truth": {
          "competing ds-oligonucleotides": {
            "bertscore": 0.651160717010498,
            "f1": 0
          },
          "DNA sequences": {
            "bertscore": 0.6740090847015381,
            "f1": 0
          },
          "a role": {
            "bertscore": 0.6715853214263916,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the molecule that is a component of phase-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0022751688957214355,
        "ground_truth": {
          "the nuclear factor-kappa B": {
            "bertscore": 0.6267264485359192,
            "f1": 0
          }
        }
      }
    },
    "What cognate DNA sequences were present in phase-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.007117629051208496,
        "ground_truth": {
          "activator protein-1": {
            "bertscore": 0.6018279194831848,
            "f1": 0
          }
        }
      }
    },
    "What did pretreatment with actinomycin D and cycloheximide significantly": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.046515583992004395,
        "ground_truth": {
          "phase-2 response": {
            "bertscore": 0.6871147751808167,
            "f1": 0
          }
        }
      }
    },
    "What is the role of cycloheximide in reducing phase-2 response?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00017887353897094727,
        "ground_truth": {
          "de novo macromolecule synthesis": {
            "bertscore": 0.5984702706336975,
            "f1": 0
          }
        }
      }
    }
  }
}